Clinical Trial Update: Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of AI-700 has been completed in patients with diminished DLCO and COPD and/or congestive heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Heart Failure

Drugs mentioned

• AI-700

Snippet

Sponsor: Acusphere | Conditions: Congestive Heart Failure, Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED